Trials / Completed
CompletedNCT01131858
Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency
A Placebo Controlled Double Blinded Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Karolinska University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: Cholecalciferol (vitamin D3) prevent respiratory tract infections in patients with primary immunodeficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vigantol | Vigantol 4000IU/day |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2010-05-27
- Last updated
- 2012-04-05
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01131858. Inclusion in this directory is not an endorsement.